# Targeted regeneration of post-radiation epithelium without promoting cancer recurrence

**Authors:** Qiwen Gan, Ya-wen Chen, Eric Genden, Michael Berger, Zhuhao Wu, Alison May, Zhe Ying

PMC · DOI: 10.21203/rs.3.rs-7320272/v1 · Research Square · 2026-02-19

## TL;DR

The study identifies a way to regenerate damaged salivary gland tissue after radiation without increasing cancer recurrence risk.

## Contribution

The study discovers that Smarca2 depletion promotes salivary gland regeneration without aiding cancer cell growth.

## Key findings

- Smarca2 depletion enhances regeneration of radiation-damaged salivary acinar cells.
- Smarca2 depletion does not promote oral squamous cell carcinoma expansion.
- The mechanism is conserved in human tissue and can be targeted with SMARCA2-targeting PROTAC degraders.

## Abstract

Cancer radiotherapy inevitably damages normal tissues, yet therapeutic activation of pro-survival or regenerative pathways frequently increases the risk of cancer recurrence. Strategies that selectively restore normal tissue without fueling malignant regrowth remain largely undefined. Using the slow dividing yet radio-responsive salivary gland and adjacent oral squamous cell carcinoma (OSCC) as paired in vivo models, we established a high-throughput genetic screening platform to quantify post-irradiation clonal expansion in both normal and malignant epithelium. Comparative screening revealed depletion of the salivary gland dominant SWI/SNF core ATPase Smarca2 as the top-ranking selective driver of salivary epithelial regeneration, in contrast to most candidates that promoted expansion in both tissues. Smarca2 depletion specifically enhanced regeneration of acinar cells, the lineage most refractory to recovery after irradiation, by suppressing terminal differentiation programs and enabling transcriptional activation of key regenerative genes. In OSCC cells, however, this regenerative switch was uncoupled from Smarca2 depletion due to tumor-specific chromatin state remodeling. Notably, this mechanism is conserved in human salivary gland tissue and can be induced using SMARCA2-targeting PROTAC degrader, a therapeutic class under active development for cancer treatment. Together, our findings suggest that Smarca2 depletion is a potent lineage-specific mechanism to replenish radiation damaged salivary epithelium without promoting OSCC expansion, a paradigm that is underexplored.

## Linked entities

- **Genes:** SMARCA2 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2) [NCBI Gene 6595], SMARCA2 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2) [NCBI Gene 6595]
- **Diseases:** oral squamous cell carcinoma (MONDO:0004958)

## Full-text entities

- **Genes:** KRT8 (keratin 8) [NCBI Gene 3856] {aka CARD2, CK-8, CK8, CYK8, K2C8, K8}, KRT14 (keratin 14) [NCBI Gene 3861] {aka CK14, EBS1, EBS1A, EBS1B, EBS1C, EBS1D}, BHLHA15 (basic helix-loop-helix family member a15) [NCBI Gene 168620] {aka BHLHB8, MIST1}, MUC7 (mucin 7, secreted) [NCBI Gene 4589] {aka MG2}, Acta2 (actin alpha 2, smooth muscle, aorta) [NCBI Gene 11475] {aka 0610041G09Rik, Actvs, SMAalpha, SMalphaA, a-SMA, alphaSMA}, KRT19 (keratin 19) [NCBI Gene 3880] {aka CK19, K19, K1CS}, SKA2 (spindle and kinetochore associated complex subunit 2) [NCBI Gene 348235] {aka FAM33A}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 26419] {aka JNK, JNK1, Prkm8, SAPK1}, Krt19 (keratin 19) [NCBI Gene 16669] {aka CK-19, EndoC, K19, Krt-1.19, Krt1-19}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Fgf7 (fibroblast growth factor 7) [NCBI Gene 14178] {aka Fgf5b, Kgf}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Fdxr (ferredoxin reductase) [NCBI Gene 14149] {aka AR}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, SMARCA2 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2) [NCBI Gene 6595] {aka BAF190, BIS, BRM, NCBRS, SAMRCA2, SNF2}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Foxa1 (forkhead box A1) [NCBI Gene 15375] {aka Hnf-3a, Hnf3a, Tcf-3a, Tcf3a}, Erg (ETS transcription factor) [NCBI Gene 13876] {aka D030036I24Rik}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, OPRPN (opiorphin prepropeptide) [NCBI Gene 58503] {aka BPLP, PRL1, PROL1, opiorphin}, Edar (ectodysplasin-A receptor) [NCBI Gene 13608] {aka ED1R, ED3, ED5, EDA-A1R, EDA3, dl}, Cdk4 (cyclin dependent kinase 4) [NCBI Gene 12567] {aka Crk3}, Hmga1 (high mobility group AT-hook 1) [NCBI Gene 15361] {aka Hmga1a, Hmga1b, Hmgi, Hmgiy, Hmgy}, AQP5 (aquaporin 5) [NCBI Gene 362] {aka AQP-5, PPKB}, HMGA1 (high mobility group AT-hook 1) [NCBI Gene 3159] {aka HMG-R, HMGA1A, HMGIY}, SERPINA1 (serpin family A member 1) [NCBI Gene 5265] {aka A1A, A1AT, AAT, PI, PI1, PRO2275}, Marcksl1 (MARCKS-like 1) [NCBI Gene 17357] {aka D4Bc1, F52, MacMARCKS, Macs2, Macs3, Mlp}, DNAH8 (dynein axonemal heavy chain 8) [NCBI Gene 1769] {aka ATPase, SPGF46, hdhc9}, ELF5 (E74 like ETS transcription factor 5) [NCBI Gene 2001] {aka ESE2}, GLB1 (galactosidase beta 1) [NCBI Gene 2720] {aka EBP, ELNR1, MPS4B}, Smarca4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) [NCBI Gene 20586] {aka BAF190A, Brg1, HP1-BP72, SNF2beta, SW1/SNF, b2b508.1Clo}, Krt14 (keratin 14) [NCBI Gene 16664] {aka CK-14, K14, Krt-1.14, Krt1-14}, CDK4 (cyclin dependent kinase 4) [NCBI Gene 1019] {aka CMM3, MCPH31, PSK-J3}, Aqp5 (aquaporin 5) [NCBI Gene 11830], CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, Myc (Myc proto-oncogene, bHLH transcription factor) [NCBI Gene 17869] {aka Myc2, Niard, Nird, bHLHe39}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, SMARCA4 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4) [NCBI Gene 6597] {aka BAF190, BAF190A, BRG1, CSS4, MRD16, OTSC12}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, Ska2 (spindle and kinetochore associated complex subunit 2) [NCBI Gene 66140] {aka 1110001A07Rik, Fam33a}, Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, Smarca2 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2) [NCBI Gene 67155] {aka 2610209L14Rik, SAMRCA2, SNF2alpha, Snf2l2, brahma, brm}
- **Diseases:** cancer (MESH:D009369), head and neck cancer (MESH:D006258), pancreatitis (MESH:D010195), lung injury (MESH:D055370), prostate cancer (MESH:D011471), OSCC (MESH:D000077195), salivary gland dysfunction (MESH:D012466), toxicity (MESH:D064420), radiation (MESH:D011832)
- **Chemicals:** 2-methyl-2-butanol (MESH:C032765), EDTA (MESH:D004492), xylazine (MESH:D014991), Iohexol (MESH:D007472), Triton X-100 (MESH:D017830), Doxycycline (MESH:D004318), MgCl2 (MESH:D015636), PTS (MESH:D010984), NaCl (MESH:D012965), EdU (MESH:C022811), 2-propanol (MESH:D019840), SDS (MESH:D012967), glycine (MESH:D005998), NaOH (MESH:D012972), sorbitol (MESH:D013012), NaN3 (MESH:D019810), oil (MESH:D009821), 2,2'-thiodiethanol (MESH:C047519), H3K27Ac (-), Amifostine (MESH:D004999), Dox (MESH:D004317), pilocarpine (MESH:D010862), halogen (MESH:D006219), PB (MESH:D007854), DMSO (MESH:D004121), DAPI (MESH:C007293), ATP (MESH:D000255)
- **Species:** Lentivirus (genus) [taxon 11646], Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** 293TN — Homo sapiens (Human), Transformed cell line (CVCL_UL49), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), MOC1 — Mus musculus (Mouse), Squamous cell carcinoma of the mouse oral cavity, Cancer cell line (CVCL_ZD32), HL1115 — Homo sapiens (Human), Transformed cell line (CVCL_9E03), MOC1/22 — Mus musculus (Mouse), Squamous cell carcinoma of the mouse oral cavity, Cancer cell line (CVCL_ZD36), D5E4 — Mus musculus (Mouse), Transformed cell line (CVCL_0E83)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12934974/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12934974/full.md

## References

134 references — full list in the complete paper: https://tomesphere.com/paper/PMC12934974/full.md

---
Source: https://tomesphere.com/paper/PMC12934974